Vaccine Hesitancy: Public Trust, Expertise, and the War on Science March 31
A virtual discussion on the public acceptance of vaccinations
Event Information (passed)
COVID-10 vaccines are currently undergoing strong public scrutiny, just as all vaccines have since the first vaccine, the smallpox vaccine, was introduced in 1796. This is the topic of an upcoming virtual talk featuring author Maya J. Goldenberg and her new book "Vaccine Hesitancy: Public Trust, Expertise, and the War on Science."
This virtual talk, taking place on March 31 at 7 p.m., is hosted by the University of Cincinnati’s Center for Public Engagement with Science (PEWS) and Cincinnati’s Mercantile Library and also sponsored by the Philosophy of Science Association (PSA).
Maya Goldenberg, a philosopher of science and medicine at the University of Guelph, and UC faculy member Angela Potochnik to discuss Goldenberg's newly published book about vaccine hesitancy.
“Among these organizations, we all share an interest in humanistic inquiry into science and into the roles science plays in our society. I like to think of these events as a way to highlight how we can use philosophy, history, and other humanistic approaches to deepen our understanding of science,” says Angela Potochnik, a UC professor of philosophy and director of UC’s Center for Public Engagement with Science.
At this event, Potochnik and Goldenberg will discuss public acceptance of vaccinations as a key component of the public’s interface with science.
Goldenberg is associate professor of philosophy in the Department of Philosophy at the University of Guelph. Her research centers on the philosophy of science and medicine, with interest in the connection between science and values.
Potochnik’s research addresses the nature of science and its successes, the relationships between science and the public, and methods in population biology. She is the author of "Idealization and the Aims of Science" (2017) and coauthor of "Recipes for Science" (2018), an introduction to scientific methods and reasoning.
“We are thrilled to host Maya Goldenberg, a philosopher of science and medicine at the University of Guelph, to discuss her newly published book about vaccine hesitancy. Public acceptance of vaccinations is a key component of the public’s interface with science,” says Potochnik.
“It may be convenient to think that vaccine hesitancy is a result of the public’s limited understanding of science, but Goldenberg argues that it has more to do with challenging issues surrounding public trust of science. COVID-19 and ensuing vaccination efforts have brought these issues to the forefront of popular dialogue, and we’re thrilled to be hosting such a timely discussion.”
Featured image at top of health care worker loading a syringe. Photo/Sam Moqadam/Unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.